Action BIO.B BIO-RAD LABORATORIES, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Bio-Rad Laboratories, Inc. Nyse

Actions

BIO.B

US0905721082

Marché Fermé - Nyse
Autres places de cotation
 22:15:00 17/05/2024 		Varia. 5j. Varia. 1 janv.
279,9 USD 0,00% Graphique intraday de Bio-Rad Laboratories, Inc. 0,00% -12,71%
14/05 Transcript : Bio-Rad Laboratories, Inc. Presents at 2024 RBC Capital Markets Global Healthcare Conference, May-14-2024 02:05 PM
08/05 BIO-RAD LABORATORIES, INC. : UBS réitère son opinion positive sur le titre ZM

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Bio-Rad Laboratories reiterates 2024 revenue growth outlook; shares slip
Bio-Rad Laboratories Q1 Non-GAAP Earnings, Revenue Decline
Earnings Flash (BIO) BIO-RAD LABORATORIES Reports Q1 Revenue $610.8M, vs. Street Est of $620.1M
Earnings Flash (BIO) BIO-RAD LABORATORIES Reports Q1 EPS $2.29, vs. Street Est of $2.14
Bio-Rad: Q1 Earnings Snapshot
Bio-Rad Reports First-Quarter 2024 Financial Results
Bio-Rad Laboratories, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Bio-Rad's Management to Participate in Fireside Chat during RBC Capital Markets Global Healthcare Conference
Bio-Rad’s Management to Participate in Fireside Chat During RBC Capital Markets Global Healthcare Conference
Bio-Rad Announces Life Science Group Management Changes
Bio-Rad Announces Life Science Group Management Changes
Bio-Rad Laboratories, Inc. Announces Executive Vice President and President Changes, Life Science Group
Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
ONCOCYTE REPORTS FULL YEAR 2023 FINANCIAL RESULTS
Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay
Oncocyte Corporation and Bio-Rad Laboratories, Inc. Partner on Global Launch of Transplant Assay
Bio-Rad Laboratories COO Andrew Last to Retire in September
Bio-Rad’s Chief Operating Officer Andrew Last to Retire
Bio-Rad Laboratories, Inc. Announces Chief Operating Officer Andrew Last to Retire
North American Morning Briefing : Focus Turns to -2-
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action BIO
  4. Action BIO.B
  5. Actualités Bio-Rad Laboratories, Inc.
  6. Autres langues